Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
High levels of CRBN isoform lacking IMiDs binding domain predicts for a worse response to IMiDs-based upfront therapy in newly diagnosed myeloma patients.
Clin Exp Med. 2023 Dec;23(8):5227-5239. doi: 10.1007/s10238-023-01205-y. Epub 2023 Oct 10.
Clin Exp Med. 2023.
PMID: 37815734
Free PMC article.
HIF-1α inhibition blocks the cross talk between multiple myeloma plasma cells and tumor microenvironment.
Borsi E, Perrone G, Terragna C, Martello M, Zamagni E, Tacchetti P, Pantani L, Brioli A, Dico AF, Zannetti BA, Rocchi S, Cavo M.
Borsi E, et al. Among authors: dico af.
Exp Cell Res. 2014 Nov 1;328(2):444-55. doi: 10.1016/j.yexcr.2014.09.018. Epub 2014 Sep 26.
Exp Cell Res. 2014.
PMID: 25257607
Item in Clipboard
Hypoxia inducible factor-1 alpha as a therapeutic target in multiple myeloma.
Borsi E, Perrone G, Terragna C, Martello M, Dico AF, Solaini G, Baracca A, Sgarbi G, Pasquinelli G, Valente S, Zamagni E, Tacchetti P, Martinelli G, Cavo M.
Borsi E, et al. Among authors: dico af.
Oncotarget. 2014 Apr 15;5(7):1779-92. doi: 10.18632/oncotarget.1736.
Oncotarget. 2014.
PMID: 24732040
Free PMC article.
Item in Clipboard
Cite
Cite